Literature DB >> 16610659

Validation of osmotic fragility test and dichlorophenol indophenol precipitation test for screening of thalassemia and Hb E.

Siripakorn Sangkitporn1, Somchai Sangkitporn, Areerat Sangnoi, Ornchira Supangwiput, Voravarn S Tanphaichitr.   

Abstract

The strategy for screening of thalassemia and Hb E by a combination of osmotic fragility (OF) test and dichlorophenol indophenol precipitation (DCIP) test was validated with 436 unrelated Thai subjects. Hemoglobin (Hb) typing, Hb A2 quantitation, PCR and DNA sequence analysis were used as confirmatory methods for diagnosis of thalassemia and hemoglobinopathy. The sensitivity and specificity of this strategy was 100% and 79.7%, respectively. The results assessed by two medical scientists were exactly the same with 93.3% accuracy in comparison with the confirmatory methods. A combination of OF and DCIP has been shown to be a reliable, rapid, simple and sensitive strategy for screening thalassemia and Hb E in the Thai population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16610659

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  4 in total

1.  Aplastic anaemia with microfilaria in marrow aspirate.

Authors:  Narender Tejwani; Seema Tyagi; Jasmita Dass
Journal:  Mediterr J Hematol Infect Dis       Date:  2012-03-16       Impact factor: 2.576

Review 2.  Hemoglobin E disorder: Newborn screening program.

Authors:  Viroj Wiwanitkit
Journal:  Indian J Hum Genet       Date:  2013-07

3.  A "One-Stop" Screening Protocol for Haemoglobinopathy Traits and Iron Deficiency in Sri Lanka.

Authors:  Angela Allen; Shiromi Perera; Luxman Perera; Rexan Rodrigo; Sachith Mettananda; Agnes Matope; Ishari Silva; Nizri Hameed; Christopher A Fisher; Nancy Olivieri; David J Weatherall; Stephen Allen; Anuja Premawardhena
Journal:  Front Mol Biosci       Date:  2019-08-09

4.  Epidemiology of thalassemia among the hill tribe population in Thailand.

Authors:  Tawatchai Apidechkul; Fartima Yeemard; Chalitar Chomchoei; Panupong Upala; Ratipark Tamornpark
Journal:  PLoS One       Date:  2021-02-11       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.